0.51429999 USD
0.0057
1.10%
Last update Dec 12, 3:29 PM EST
Market closed
Day range
0.49259999
0.51899999
Previous close
0.51999998
Open
0.51059997
Access this stock data via API
Subscribe
Elite Pharmaceuticals Inc.
0.51
0.01
1.10%

Financials

Income statement

Fiscal date 2025 2024 2023 2022
Total reported revenue 84.0M 56.6M 34.2M 32.3M
Cost of revenue 44.0M 30.3M 17.6M 17.5M
Gross profit 40.1M 26.4M 16.6M 14.8M
Operating expense
Research & development 8.0M 6.9M 6.2M 4.1M
Selling general and admin 9.2M 7.3M 5.2M 4.5M
Other operating expenses
Operating income 21.2M 10.8M 4.0M 5.1M
Non operating interest income
Income 20.9K 20.9K 7.5K 126
Expense 772.4K 588.6K 1.1M 191.8K
Other income expense -20.5M -9.8M 1.1M 1.4M
Pretax income -52.1K 463.1K 4.0M 6.3M
Tax provision 4.3M -19.6M 424.0K -1.7M
Net income -4.3M 20.1M 3.6M 8.9M
Basic EPS 0 0.0 0.0 0.0
Diluted EPS 0 0.0 0.0 0.0
Basic average shares 1.1B 1.0B 1.0B 1.0B
Diluted average shares 1.1B 1.0B 1.0B 1.0B
EBITDA 23.3M 6.5M 5.3M 6.5M
Net income from continuing op. -4.3M 20.1M 3.6M 8.9M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed (non-working day)
Pre-market opens in 17 hours 20 minutes

12:39
00:00
23:59

Trading Hours (Monday - Friday):

Pre-market
06:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 17:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).